文献速递糖尿病肥胖与代谢综合征

身高及身高组成与2型糖尿病发病的关联:心血管代谢危险因素的中介效应

Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors.
PubMed 文献 · Diabetologia · 2019-09-09

在EPIC-Potsdam病例队列研究中,对2500名随机亚队列个体及698例新发2型糖尿病病例分析显示,校正年龄、生活方式、教育及腰围后,身高每增加10cm,男性糖尿病风险HR为0.59(95%CI 0.47-0.75),女性为0.67(95%CI 0.51-0.88)。腿长在男女中均与较低风险相关,但男性仅在校正总身高后显著。肝脏脂肪、甘油三酯、脂联素和C反应蛋白的调整大幅减弱了身高与糖尿病风险的关联,尤其在女性中。

要点

  • 腿长与糖尿病风险负相关,男性中该关联独立于总身高。
  • 肝脏脂肪和心血管代谢标志物部分介导了身高与糖尿病风险的负关联。

核心结论

  • 身高与2型糖尿病风险呈负相关,男性中该关联 largely 归因于腿长。
  • 负相关可能部分由较低肝脏脂肪含量和更有利的心血管代谢谱驱动。

研究设计与样本

  • EPIC-Potsdam研究中的病例队列设计,共26437名提供血样的参与者。
  • 随机选取2500名亚队列个体(2029名基线无糖尿病且有完整数据)。
  • 7年随访期间全队列识别820例新发糖尿病,经排除后698例纳入分析。

主要发现

  • 校正年龄、生活方式、教育及腰围后,身高每10cm的糖尿病风险HR:男性0.59(95%CI 0.47-0.75),女性0.67(95%CI 0.51-0.88)。
  • 腿长与较低糖尿病风险相关(男女均相关),但男性仅在调整总身高后关联仍显著。
  • 调整肝脏脂肪、甘油三酯、脂联素和C反应蛋白后,身高与糖尿病风险的关联大幅减弱,尤其在女性中。

临床怎么用

  • 身高较矮者可能需更关注2型糖尿病风险,尤其结合肝脏脂肪和心血管代谢指标评估。
  • 改善肝脏脂肪和心血管代谢危险因素或有助于降低矮身材个体的糖尿病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: This study aimed to evaluate associations of height as well as components of height (sitting height and leg length) with risk of type 2 diabetes and to explore to what extent associations are explainable by liver fat and cardiometabolic risk markers. METHODS: A case-cohort study within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study comprising 26,437 participants who provided blood samples was designed. We randomly selected a subcohort of 2500 individuals (2029 diabetes-free at baseline and with anamnestic, anthropometrical and metabolic data for analysis). Of the 820 incident diabetes cases identified in the full cohort during 7 years of follow-up, 698 remained for analyses after similar exclusions. RESULTS: After adjustment for age, potential lifestyle confounders, education and waist circumference, greater height was related to lower diabetes risk (HR per 10 cm, men 0.59 [95% CI 0.47, 0.75] and women 0.67 [0.51, 0.88], respectively). Leg length was related to lower risk among men and women, but only among men if adjusted for total height. Adjustment for liver fat and triacylglycerols, adiponectin and C-reactive protein substantially attenuated associations between height and diabetes risk, particularly among women. CONCLUSIONS/INTERPRETATION: We observed inverse associations between height and risk of type 2 diabetes, which was largely related to leg length among men. The inverse associations may be partly driven by lower liver fat content and a more favourable cardiometabolic profile.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Wittenbecher C, Kuxhaus O, Boeing H, et al. Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors. Diabetologia. 2019. PMID: 31501920. doi:10.1007/s00125-019-04978-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。